Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 074559

Expand all

NITROGLYCERIN (NITROGLYCERIN)
0.1MG/HR
Marketing Status: Prescription

Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.1MG/HR
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB2
Application Number: A074559
Product Number: 004
Approval Date: Feb 6, 1998
Applicant Holder Full Name: MYLAN TECHNOLOGIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

NITROGLYCERIN (NITROGLYCERIN)
0.2MG/HR
Marketing Status: Prescription

Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.2MG/HR
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB2
Application Number: A074559
Product Number: 003
Approval Date: Aug 30, 1996
Applicant Holder Full Name: MYLAN TECHNOLOGIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

NITROGLYCERIN (NITROGLYCERIN)
0.4MG/HR
Marketing Status: Prescription

Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.4MG/HR
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB2
Application Number: A074559
Product Number: 002
Approval Date: Aug 30, 1996
Applicant Holder Full Name: MYLAN TECHNOLOGIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

NITROGLYCERIN (NITROGLYCERIN)
0.6MG/HR
Marketing Status: Prescription

Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.6MG/HR
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB2
Application Number: A074559
Product Number: 001
Approval Date: Aug 30, 1996
Applicant Holder Full Name: MYLAN TECHNOLOGIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information